Remond Moningka

Statistics

Publications

Citations

H-Index

Active since

2005

Affiliations

The University of Texas at Arlington(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Remond Moningka is an author at The University of Texas at Arlington specializing in medicinal chemistry, retrosynthetic analysis, and drug discovery.

Publications per year

2005–2022

Publications

Cyclization reactions of N-acryloyl-2-aminobenzaldehyde derivatives: formal total synthesis of martinellic acid

Yong He, Hossen Mahmud, Remond Moningka et al. · Tetrahedron · 2006 · 31 citations

Natural Sciences, Chemistry, Organic Chemistry +3

A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells

Keith P. Moore, Adam G. Schwaid, Matthew Tudor et al. · ACS Chemical Biology · 2022 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Formal total synthesis of (±)-martinellic acid

Yong He, Remond Moningka, Carl J. Lovely · Tetrahedron Letters · 2005 · 26 citations

Natural Sciences, Chemistry, Organic Chemistry +4

Fragment-based lead discovery of a novel class of small molecule antagonists of neuropeptide B/W receptor subtype 1 (GPR7)

Remond Moningka, F. Anthony Romero, Nicholas B. Hastings et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–4 of 4